85 completed, 26 terminated, 16 recruiting, 14 unknown. 167 Phase 1, 66 Phase 2.
Follow Crohn Disease: new trials by email Literature Review of Crohn Disease trials Research Report on Crohn Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LMT503 First-in-human SAD, MAD, and FE Study LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative | Phase 1 | Not yet recruiting | Lmito Therapeutics Inc. | 72 | 2027-03-01 | 2026-09-01 |
| An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates Duvakitug - Ulcerative Colitis, Crohn's Disease | Phase 1 | Not yet recruiting | Sanofi | 25 | 2026-11-03 | 2026-11-06 |
| R-3750 in Patients With Crohn's Disease R-3750, Placebo - Crohn Disease (CD) | Phase 1 | Not yet recruiting | Rise Therapeutics LLC | 40 | 2026-11-01 | 2026-08-28 |
| Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants CM551, Placebo - Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | Phase 1 | Not yet recruiting | Keymed Biosciences Co.Ltd | 48 | 2026-10-01 | 2026-10-28 |
| Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study Oxygen Gas for Inhalation, Standard of care - Inflammatory Bowel Disease (IBD), Crohn Disease | Phase 1 / Phase 2 | Not yet recruiting | University of British Columbia | 54 | 2026-09-01 | 2026-08-26 |
| A Phase 1 Study of ATORM-C in Patients With Crohn's Disease Autologous Adult Stem Cell-Derived Intestinal Organoid - Crohn's Diseases, Crohn's Disease | Phase 1 | Recruiting | ORGANOIDSCIENCES LTD. | 18 | 2026-09-01 | 2026-09-16 |
| Xylitol Use for Decolonization of C. Difficile in Patients With IBD Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection | Phase 1 | Not yet recruiting | Brigham and Women's Hospital | 99 | 2026-08-01 | 2026-02-25 |
| A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult BDHK-2009 Tablets, Placebo - Ulcerative Colitis (UC), Ulcerative Colitis (Disorder) | Phase 1 | Recruiting | Benethera (Shaoxing) Biotechnology Co., Ltd. | 68 | 2026-05-18 | 2026-06-08 |
| Clostridium Butyricum in Stenosing Crohn's Disease Clostridum Butyricum Capsule, Trehalose - Crohn Disease (CD) | Phase 1 / Phase 2 | Recruiting | San Giovanni Addolorata Hospital | 40 | 2026-05-08 | 2026-09-04 |
| BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T - Inflammatory Bowel Diseases (IBD) | Phase 1 / Phase 2 | Not yet recruiting | iCell Gene Therapeutics | 18 | 2026-04-07 | 2026-04-22 |
| Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients injection of CNK-UT009 - Inflamatory Bowel Disease, Crohn Disease (CD) | Phase 1 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2026-04-01 | 2026-02-18 |
| Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease 25mg adalimumab-680LT and 15/25 mg risankizumab-800CW, Adalimumab-680LT 25mg, Risankizumab-800CW 15 mg/25 mg - Ulcerative Colitis (UC), Crohn Disease (CD) | Phase 1 / Phase 2 | Not yet recruiting | University Medical Center Groningen | 30 | 2026-01-15 | 2026-01-14 |
| Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease injection of thawed SVF - Crohn Disease (CD) | Phase 1 / Phase 2 | Recruiting | Assistance Publique Hopitaux De Marseille | 25 | 2025-12-30 | 2026-06-05 |
| The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients Vitamin D3 (Cholecalciferol) - Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease) | Phase 1 | Active not recruiting | Terry Ponich | 150 | 2025-11-05 | 2026-10-05 |
| A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease PALI-2108 - Fibrostenotic Crohn's Disease | Phase 1 | Active not recruiting | Palisade Bio | 6 | 2025-10-17 | 2026-02-23 |
| Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System, Prednisone/Methylprenisolone, Palifermin - Crohn Disease | Phase 1 / Phase 2 | Not yet recruiting | Stanford University | 14 | 2025-07-01 | 2025-05-23 |
| Treatment of Moderate to Severe Refractory Crohn's Disease TRX103, Cyclophosphamide - Crohns Disease | Phase 1 / Phase 2 | Recruiting | Tr1X, Inc. | 39 | 2025-05-05 | 2025-12-10 |
| Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula AdMSC (CellReady®) - Crohn Disease | Phase 1 / Phase 2 | Recruiting | University Hospital, Toulouse | 9 | 2025-03-12 | 2025-12-24 |
| Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. Ustekinumab - Psoriasis, Crohn Disease | Phase 1 | Recruiting | University Medical Center Groningen | 56 | 2025-01-06 | 2025-01-15 |
| A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants GSK4528287, Placebo - Colitis, Ulcerative | Phase 1 | Active not recruiting | GlaxoSmithKline | 48 | 2024-11-18 | 2026-08-26 |
Showing 20 of 167. Sign in to see all of them.
Colitis, Ulcerative (46) · Inflammatory Bowel Diseases (43) · Arthritis, Rheumatoid (8) · Arthritis, Psoriatic (6) · Autoimmune Diseases (6) · Fistula (6) · Inflammation (5) · Rectal Fistula (5) · Spondylitis, Ankylosing (4) · Axial Spondyloarthritis (3) · Psoriasis (3) · Arthritis, Juvenile (2) · Colitis (2) · Colonic Neoplasms (2)
Gastroenteritis (167) · Digestive System Diseases (166) · Gastrointestinal Diseases (166) · Intestinal Diseases (166) · Inflammatory Bowel Diseases (124) · Colonic Diseases (50) · Colitis (45) · Pathological Conditions, Signs and Symptoms (23) · Pathological Conditions, Anatomical (15) · Immune System Diseases (11) · Arthritis (9) · Joint Diseases (9) · Musculoskeletal Diseases (9) · Rectal Diseases (9) · Skin and Connective Tissue Diseases (9)
Fecal Microbiota Transplantation (8) · Cyclophosphamide (4) · Ustekinumab (3) · Antilymphocyte Serum (2) · Certolizumab Pegol (2) · Cholecalciferol (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Infliximab (2) · Melphalan (2) · Mercaptopurine (2) · Mesna (2) · Methylprednisolone (2) · Midazolam (2) · Nivolumab (2)
GlaxoSmithKline (6) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · AstraZeneca (5) · University Medical Center Groningen (5) · Anthony Lembo (4) · Meir Medical Center (4) · Stanford University (4) · Mayo Clinic (3) · Teva GTC (3) · The Cleveland Clinic (3) · Assistance Publique Hopitaux De Marseille (2) · Direct Biologics, LLC (2) · Janssen Research & Development, LLC (2) · Jiangsu Topcel-KH Pharmaceutical Co., Ltd. (2) · Medtronic - MITG (2)
United States (74) · Netherlands (15) · Canada (11) · China (11) · Australia (10) · United Kingdom (10) · Belgium (9) · France (8) · Germany (8) · Israel (8) · Spain (7) · Italy (4) · South Korea (4) · Switzerland (4) · Poland (3)
Amy Lightner, MD (6) · Yaron Ilan, MD (3) · Alka Goyal, MD (2) · Bill Arana (2) · David Suskind, MD (2) · David Ziring, MD (2) · Fred Konikoff, professor (2)
PMID 17560413, PMID 38580386, PMID 20736987, PMID 23059643, PMID 23648372, PMID 25162366, PMID 25647155, PMID 26116801, PMID 27412883, PMID 27542133, PMID 28349233, PMID 28778448, PMID 28814432, PMID 28847751, PMID 29030361, PMID 29321063, PMID 30710527, PMID 31380382, PMID 31784432, PMID 31792136, PMID 33310655, PMID 33571293, PMID 33599356, PMID 33676969, PMID 34389161, PMID 35262901, PMID 35470301, PMID 36322714, PMID 36732049, PMID 37004656, PMID 37904247, PMID 38365502, PMID 39707077, PMID 39855667, PMID 40254304, PMID 40357993, PMID 41469061, PMID 41895287, PMID 42012633, PMID 42049742, PMID 42334201
2015 (2), 2016 (2), 2017 (2), 1UL1RR025014-01 (1), 2009 (1), 2014 (1), 2018 (1), 2019 (1), 2023 (1), 2025 (1), P50DK083007 (1), R01DK126448 (1), R21AT001628 (1), R21AT002534 (1), UL1RR024150 (1)